“…81 The CQDs have also been used for drug delivery in other researches, including passivated CQDs with polyaminecontaining organosilane molecules for delivery of DOX, 105 organophilic CQDs for anticancer drug curcumin delivery with high loading efficiency and rapid penetration into the HeLa cells, 178 CQDs synthesized through hydrothermal treatment of pasteurized milk for delivery of lisinopril (Lis) to HeLa cells, 179 CQDs/calcium alginate hydrogel lm for delivery of glycopeptides antibiotic vancomycin in the gastrointestinal tract, 180 CQDs/mesoporous silica nanocarriers for delivery of DOX, 181 functionalized and surface passivated CQDs for delivery of DOX to the MCF-7 cells, 182 and CQDs/hydroxyapatite hybrid nanorods for delivery of DOX to the HeLa cells and human prostatic cancer (PC-3) cells. 183 The CQDs have been used in multifunctional platforms for drug delivery and magnetic delivery and/or MRI agents and/or simultaneous co-delivery of two or more drugs, including multi-functional DDS of CQDs and DOX and heparin as an auxiliary medicine for delivery to the A549 cells, Fe 3 O 4 @CQDs coated single-walled carbon nanotubes loaded with DOX and conjugated with an sgc8c aptamer as a platform for combining cancer photothermal therapy, chemotherapy, and photodynamic therapy, 185 and magnetic gadolinium oxide-iron oxide core, mesoporous silica shell gated with boronic acid functionalized CQDs for drug delivery of anticancer drug 5-uorouracil to HePG2 cancer cells which the platform acts as MRI agent and optical imaging agent as well as stimuli-responsive DDS. 186…”